<VariationArchive RecordType="classified" VariationID="12380" VariationName="NM_000546.6(TP53):c.475_481dup (p.Ala161fs)" VariationType="Duplication" Accession="VCV000012380" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2023-09-03" DateCreated="2013-04-04" MostRecentSubmission="2023-09-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="27419" VariationID="12380">
      <GeneList>
        <Gene Symbol="TP53" FullName="tumor protein p53" GeneID="7157" HGNC_ID="HGNC:11998" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7668421" stop="7687490" display_start="7668421" display_stop="7687490" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7571719" stop="7590867" display_start="7571719" display_stop="7590867" Strand="-" />
          </Location>
          <OMIM>191170</OMIM>
          <Haploinsufficiency last_evaluated="2021-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TP53">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TP53">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000546.6(TP53):c.475_481dup (p.Ala161fs)</Name>
      <CanonicalSPDI>NC_000017.11:7675130:CCATGGC:CCATGGCCCATGGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7675130" stop="7675131" display_start="7675130" display_stop="7675131" variantLength="7" positionVCF="7675130" referenceAlleleVCF="G" alternateAlleleVCF="GCCATGGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7578448" stop="7578449" display_start="7578448" display_stop="7578449" variantLength="7" positionVCF="7578448" referenceAlleleVCF="G" alternateAlleleVCF="GCCATGGC" />
      </Location>
      <ProteinChange>A2fs</ProteinChange>
      <ProteinChange>A122fs</ProteinChange>
      <ProteinChange>A161fs</ProteinChange>
      <ProteinChange>A29fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_321" sequenceAccession="LRG_321">
            <Expression>LRG_321:g.17414_17420dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_321t1" sequenceAccession="LRG_321t1">
            <Expression>LRG_321t1:c.475_481dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_321p1" sequenceAccession="LRG_321p1" change="p.Ala161fs">
            <Expression>LRG_321p1:p.Ala161fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.7578449_7578455dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.7578449_7578455dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.7675131_7675137dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.7675131_7675137dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_017013.2" sequenceAccession="NG_017013" sequenceVersion="2" change="g.17414_17420dup">
            <Expression>NG_017013.2:g.17414_17420dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000546.6" sequenceAccession="NM_000546" sequenceVersion="6" change="c.475_481dup" MANESelect="true">
            <Expression>NM_000546.6:c.475_481dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000537.3" sequenceAccession="NP_000537" sequenceVersion="3" change="p.Ala161fs">
            <Expression>NP_000537.3:p.Ala161fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126112.3" sequenceAccession="NM_001126112" sequenceVersion="3" change="c.475_481dup">
            <Expression>NM_001126112.3:c.475_481dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001119584.1" sequenceAccession="NP_001119584" sequenceVersion="1" change="p.Ala161fs">
            <Expression>NP_001119584.1:p.Ala161fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126113.3" sequenceAccession="NM_001126113" sequenceVersion="3" change="c.475_481dup">
            <Expression>NM_001126113.3:c.475_481dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001119585.1" sequenceAccession="NP_001119585" sequenceVersion="1" change="p.Ala161fs">
            <Expression>NP_001119585.1:p.Ala161fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126114.3" sequenceAccession="NM_001126114" sequenceVersion="3" change="c.475_481dup">
            <Expression>NM_001126114.3:c.475_481dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001119586.1" sequenceAccession="NP_001119586" sequenceVersion="1" change="p.Ala161fs">
            <Expression>NP_001119586.1:p.Ala161fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126115.2" sequenceAccession="NM_001126115" sequenceVersion="2" change="c.79_85dup">
            <Expression>NM_001126115.2:c.79_85dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001119587.1" sequenceAccession="NP_001119587" sequenceVersion="1" change="p.Ala29fs">
            <Expression>NP_001119587.1:p.Ala29fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126116.2" sequenceAccession="NM_001126116" sequenceVersion="2" change="c.79_85dup">
            <Expression>NM_001126116.2:c.79_85dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001119588.1" sequenceAccession="NP_001119588" sequenceVersion="1" change="p.Ala29fs">
            <Expression>NP_001119588.1:p.Ala29fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126117.2" sequenceAccession="NM_001126117" sequenceVersion="2" change="c.79_85dup">
            <Expression>NM_001126117.2:c.79_85dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001119589.1" sequenceAccession="NP_001119589" sequenceVersion="1" change="p.Ala29fs">
            <Expression>NP_001119589.1:p.Ala29fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126118.2" sequenceAccession="NM_001126118" sequenceVersion="2" change="c.358_364dup">
            <Expression>NM_001126118.2:c.358_364dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001119590.1" sequenceAccession="NP_001119590" sequenceVersion="1" change="p.Ala122fs">
            <Expression>NP_001119590.1:p.Ala122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276695.3" sequenceAccession="NM_001276695" sequenceVersion="3" change="c.358_364dup">
            <Expression>NM_001276695.3:c.358_364dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263624.1" sequenceAccession="NP_001263624" sequenceVersion="1" change="p.Ala122fs">
            <Expression>NP_001263624.1:p.Ala122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276696.3" sequenceAccession="NM_001276696" sequenceVersion="3" change="c.358_364dup">
            <Expression>NM_001276696.3:c.358_364dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263625.1" sequenceAccession="NP_001263625" sequenceVersion="1" change="p.Ala122fs">
            <Expression>NP_001263625.1:p.Ala122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276697.3" sequenceAccession="NM_001276697" sequenceVersion="3" change="c.-3_4dup">
            <Expression>NM_001276697.3:c.-3_4dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263626.1" sequenceAccession="NP_001263626" sequenceVersion="1" change="p.Ala2fs">
            <Expression>NP_001263626.1:p.Ala2fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276698.3" sequenceAccession="NM_001276698" sequenceVersion="3" change="c.-3_4dup">
            <Expression>NM_001276698.3:c.-3_4dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263627.1" sequenceAccession="NP_001263627" sequenceVersion="1" change="p.Ala2fs">
            <Expression>NP_001263627.1:p.Ala2fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276699.3" sequenceAccession="NM_001276699" sequenceVersion="3" change="c.-3_4dup">
            <Expression>NM_001276699.3:c.-3_4dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263628.1" sequenceAccession="NP_001263628" sequenceVersion="1" change="p.Ala2fs">
            <Expression>NP_001263628.1:p.Ala2fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276760.3" sequenceAccession="NM_001276760" sequenceVersion="3" change="c.358_364dup">
            <Expression>NM_001276760.3:c.358_364dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263689.1" sequenceAccession="NP_001263689" sequenceVersion="1" change="p.Ala122fs">
            <Expression>NP_001263689.1:p.Ala122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276761.3" sequenceAccession="NM_001276761" sequenceVersion="3" change="c.358_364dup">
            <Expression>NM_001276761.3:c.358_364dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263690.1" sequenceAccession="NP_001263690" sequenceVersion="1" change="p.Ala122fs">
            <Expression>NP_001263690.1:p.Ala122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA278881" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="191170.0036" DB="OMIM" />
        <XRef Type="rs" ID="863223301" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000546.6(TP53):c.475_481dup (p.Ala161fs) AND Choroid plexus papilloma" Accession="RCV000013179" Version="23">
        <ClassifiedConditionList TraitSetID="3356">
          <ClassifiedCondition DB="MedGen" ID="C0205770">Choroid plexus papilloma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2002-05-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000546.6(TP53):c.475_481dup (p.Ala161fs) AND Bone osteosarcoma" Accession="RCV000013180" Version="22">
        <ClassifiedConditionList TraitSetID="3348">
          <ClassifiedCondition DB="MedGen" ID="C0585442">Bone osteosarcoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2002-05-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2002-05-20" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2023-09-03">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12085209</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3356" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5730" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Choroid plexus papilloma</ElementValue>
                <XRef ID="Choroid+Plexus+Papilloma/1393" DB="Genetic Alliance" />
                <XRef ID="HP:0200022" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0009837" DB="MONDO" />
                <XRef ID="18021007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Papilloma of choroid plexus</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CPP</ElementValue>
                <XRef Type="MIM" ID="260500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4214" />
                <XRef ID="4214" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="251899" DB="Orphanet" />
              <XRef ID="2807" DB="Orphanet" />
              <XRef ID="C0205770" DB="MedGen" />
              <XRef ID="MONDO:0009837" DB="MONDO" />
              <XRef Type="MIM" ID="260500" DB="OMIM" />
              <XRef Type="primary" ID="HP:0200022" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3348" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3682" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Bone osteosarcoma</ElementValue>
                <XRef ID="MONDO:0002629" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteosarcoma, somatic</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">OSRC</ElementValue>
                <XRef Type="MIM" ID="259500" DB="OMIM" />
              </Symbol>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/bone.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Bone Cancer, 2023</CitationText>
              </Citation>
              <XRef ID="668" DB="Orphanet" />
              <XRef ID="C0585442" DB="MedGen" />
              <XRef ID="MONDO:0002629" DB="MONDO" />
              <XRef Type="MIM" ID="259500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="33426" SubmissionDate="2013-04-09" DateLastUpdated="2023-09-03" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="191170.0036_CHOROID PLEXUS PAPILLOMA" title="TP53, 7-BP INS, NT13160_CHOROID PLEXUS PAPILLOMA" />
        <ClinVarAccession Accession="SCV000033426" DateUpdated="2023-09-03" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-05-20">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 29-year-old woman with a rare choroid plexus papilloma (260500) who had had, at the age of 22 years, an osteosarcoma (259500), Rutherford et al. (2002) detected a germline 7-bp insertion in exon 5 of the p53 gene. The alteration was predicted to produce amino acid substitutions beginning with alanine to glycine at position 161 and a stop codon at position 182 in the mutated protein. Two assays of p53 function gave apparently wildtype results on peripheral blood lymphocytes from this woman. The mutant allele was expressed either at very low levels or not at all in phytohemagglutinin-stimulated lymphocytes. Furthermore, the mutant protein was completely nonfunctional in terms of its ability to transactivate a series of p53-responsive genes, to transrepress a target gene, and to inhibit colony growth in transfected cells. However, data from irradiated peripheral blood lymphocytes and transfected cells suggested that this truncated, mutant protein retained significant ability to induce apoptosis.</Attribute>
              <Citation>
                <ID Source="PubMed">12085209</ID>
              </Citation>
              <XRef DB="OMIM" ID="260500" Type="MIM" />
              <XRef DB="OMIM" ID="259500" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TP53" />
          </GeneList>
          <Name>TP53, 7-BP INS, NT13160</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">7-BP INS, NT13160</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="191170.0036" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CHOROID PLEXUS PAPILLOMA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="33427" SubmissionDate="2013-04-09" DateLastUpdated="2023-09-03" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="191170.0036_OSTEOSARCOMA" title="TP53, 7-BP INS, NT13160_OSTEOSARCOMA" />
        <ClinVarAccession Accession="SCV000033427" DateUpdated="2023-09-03" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-05-20">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 29-year-old woman with a rare choroid plexus papilloma (260500) who had had, at the age of 22 years, an osteosarcoma (259500), Rutherford et al. (2002) detected a germline 7-bp insertion in exon 5 of the p53 gene. The alteration was predicted to produce amino acid substitutions beginning with alanine to glycine at position 161 and a stop codon at position 182 in the mutated protein. Two assays of p53 function gave apparently wildtype results on peripheral blood lymphocytes from this woman. The mutant allele was expressed either at very low levels or not at all in phytohemagglutinin-stimulated lymphocytes. Furthermore, the mutant protein was completely nonfunctional in terms of its ability to transactivate a series of p53-responsive genes, to transrepress a target gene, and to inhibit colony growth in transfected cells. However, data from irradiated peripheral blood lymphocytes and transfected cells suggested that this truncated, mutant protein retained significant ability to induce apoptosis.</Attribute>
              <Citation>
                <ID Source="PubMed">12085209</ID>
              </Citation>
              <XRef DB="OMIM" ID="260500" Type="MIM" />
              <XRef DB="OMIM" ID="259500" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TP53" />
          </GeneList>
          <Name>TP53, 7-BP INS, NT13160</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">7-BP INS, NT13160</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="191170.0036" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">OSTEOSARCOMA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="33427" TraitType="Disease" MappingType="Name" MappingValue="OSTEOSARCOMA" MappingRef="Alternate">
        <MedGen CUI="C0029463" Name="Osteosarcoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="33426" TraitType="Disease" MappingType="Name" MappingValue="CHOROID PLEXUS PAPILLOMA" MappingRef="Preferred">
        <MedGen CUI="C0205770" Name="Choroid plexus papilloma" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

